Zuellig Pharma, a leading healthcare services provider in Asia, has been presented with four leadership and sustainability awards, in both individual and enterprise categories, at the recent Asia Corporate Excellence and Sustainability (ACES) Awards. Organised by MORS Group, the annual ACES Awards is a prestigious accolade that recognises inspiring leaders, sustainability advocates as well as businesses' contributions to their communities and the world.

The four titles achieved include 'Top Sustainability Advocates in Asia' by Zuellig Pharma's Regional Office, 'Industry Champions of the Year' by Zuellig Pharma Singapore, 'Community Initiative' by PT Anugerah Pharmindo Lestari (APL), Zuellig Pharma's subsidiary in Indonesia, and 'Outstanding Leaders in Asia' under the Individual awards category by APL's President Director Christophe Piganiol.

Zuellig Pharma's Regional Office was recognised for integrating various CSR initiatives into its policies and operations, having a high level of employees and top management involvement in the programmes and having a genuine interest in the wellbeing of all of its stakeholders. Zuellig Pharma Singapore was awarded for its leadership in the healthcare space displayed through commendable best practices and its ability to overcome ongoing challenges and changes in the healthcare industry.

APL achieved the Community Initiative award as a recognition for leading programmes and initiatives that contribute significantly to community causes. The Outstanding Leaders in Asia award was presented to Christophe Piganol for demonstrating sound leadership and spearheading the company's growth and prominence.

"Zuellig Pharma has demonstrated how huge corporations can spearhead sustainability through the push down effect from top management, resulting in considerable change organisationally, as well as via the ripple effect to its suppliers and consumers,” said Shanggari Balakrishnan, Chief Executive Officer, MORS Group.

"We are honoured to have been presented with four titles at the ACES Awards. This is yet another testament to the dedication and hard work of our teams to make healthcare more accessible to the communities we serve, with our sustainability agenda as an integral part of the way we run our business. The Regional, Singapore and APL teams' efforts at organising various community and employee initiatives have made a real difference to the health of our communities, and we look forward to scaling greater heights as we continue navigating these challenging times. Congratulations to all the teams involved,” shared John Graham, Chief Executive Officer, Zuellig Pharma.

We are proud to be the award recipient of this esteemed award. It is an affirmation of our corporate excellence, reputation, and capabilities that we have established locally in the past 81 years. Our strong BCP framework coupled with the resiliency in our workforce have allowed us to navigate through the challenges from COVID-19. We will continue to strengthen our service offerings and drive innovation to ensure healthcare remains accessible to the community we serve in Singapore,” commented Tan Yan Ann, Chief Executive, Zuellig Pharma Singapore.

"In APL, sustainability has been embedded in our DNA. This recognition energises us to continue embedding sustainability in all that we do to build a healthier future for Indonesia. Additionally, the distinction that comes from being recognised as an outstanding leader in Asia strengthens my resolve to provide an even more conducive environment for the team to develop, and to help the community at large with a particular focus to develop the next generation of leaders who are passionate to drive innovation that makes healthcare more accessible to the Indonesian people," said Christophe Piganiol, President Director, APL.

The ACES Awards will be presented at a virtual event. More information about the ACES Awards and its 2021 winners can be found here: